Giordano, F. A., Layer, J., Leonardelli, S., Friker, L. L., Turiello, R., Corvino, D., . . . Hölzel, M. (2024). L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: Dose escalation of the phase I/II GLORIA trial. Nature Communications, 15, . https://doi.org/10.1038/s41467-024-48416-9
Chicago-Zitierstil (17. Ausg.)Giordano, Frank Anton, et al. "L-RNA Aptamer-based CXCL12 Inhibition Combined with Radiotherapy in Newly-diagnosed Glioblastoma: Dose Escalation of the Phase I/II GLORIA Trial." Nature Communications 15 (2024). https://doi.org/10.1038/s41467-024-48416-9.
MLA-Zitierstil (9. Ausg.)Giordano, Frank Anton, et al. "L-RNA Aptamer-based CXCL12 Inhibition Combined with Radiotherapy in Newly-diagnosed Glioblastoma: Dose Escalation of the Phase I/II GLORIA Trial." Nature Communications, vol. 15, 2024, https://doi.org/10.1038/s41467-024-48416-9.